Revenue (Tables)

9 Months Ended

Sep. 30, 2019

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table represents our revenues disaggregated by geography (in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
Geography	2019		2018		2019		2018
Europe, the Middle East and Africa	$	31,474	$	30,759	$	96,830	$	104,150
Other Foreign	53,398		51,569		156,353		154,278
Total Foreign	84,872		82,328		253,183		258,428
United States	222,599		244,841		697,502		801,234
Total Revenues	$	307,471	$	327,169	$	950,685	$	1,059,662

The following table represents our revenues disaggregated by product (in thousands):

	For the three months ended September 30,				For the nine months ended September 30,
Product line	2019		2018		2019		2018
Infusion Consumables	$	119,745	$	117,797	$	357,994	$	361,490
IV Solutions	98,159		114,433		313,976		394,198
Infusion Systems	78,932		81,456		244,523		263,271
Critical Care	10,635		13,483		34,192		40,703
Total Revenues	$	307,471	$	327,169	$	950,685	$	1,059,662

Contract with Customer, Asset and Liability [Table Text Block]

The following table presents our changes in the contract balances for the nine months ended September 30, 2019 and 2018 (in thousands):

	Contract Liabilities
Beginning balance, January 1, 2019	$	(4,282	)
Equipment revenue recognized	3,619
Equipment revenue deferred due to implementation	(6,869		)
Software revenue recognized	2,955
Software revenue deferred due to implementation	(3,115		)
Ending balance, September 30, 2019	$	(7,692	)
Beginning balance, January 1, 2018	$	(7,066	)
Equipment revenue recognized	3,136
Equipment revenue deferred due to implementation	(4,086		)
Software revenue recognized	5,649
Software revenue deferred due to implementation	(5,507		)
Ending balance, September 30, 2018	$	(7,874	)